Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Product name:
OCTREOSCAN
DIN:
02329271
Product Monograph/Veterinary Labelling:
Date:
2021-08-13
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
CURIUM CANADA INC
217 & 220
2572 Boul. Daniel-Johnson
Laval
Quebec
Canada
H7T 2R3
Class:
Radiopharmaceutical
Dosage form(s):
Solution , Powder For Solution , Kit
Route(s) of administration:
Intravenous
Number of active ingredient(s):
2
Schedule(s):
Schedule C
American Hospital Formulary Service (AHFS): See footnote 3
36:68.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
V09IB01 INDIUM 111 IN PENTETREOTIDE
Active ingredient group (AIG) number:See footnote5
0252623001
| Active ingredient(s) | Strength |
|---|---|
| INDIUM IN 111 CHLORIDE | 111 MBq / ML |
| PENTETREOTIDE | 10 MCG / VIAL |